CASE Op-Ed in Townhall.Com: House Committee Must Safeguard American Healthcare Innovation From China
April 26, 2023 If somebody stole your car, hacked your bank account, and emptied your retirement savings, your response […]
April 25, 2023 For most consumers, booking an airline ticket is a matter of clicking or scrolling through online […]
March 31, 2023 Over the course of the last month the Department of Education has intensified an effort to […]
March 30, 2023 https://bit.ly/40MyzfR For someone seemingly devoted to the creed “big is bad,” Federal Trade Commission (FTC) Chair Lina […]
March 21, 2023 Gerard Scimeca Chairman, CASE Since the advent of alcohol excise taxes, state and federal governments have […]
March 9, 2023 President Biden traveled to Philadelphia today to sell Americans on his budget proposal for the 2024 […]
Gerard Scimeca Chairman, CASE March 9, 2023 Though it may be impossible to pinpoint exactly when our current digital […]
Gerard Scimeca Chairman, CASE February 21, 2023 There is no more glowing piece of evidence pointing to the utter […]
February 15, 2023 A proverbial “bad penny” of legislative proposals is back as big business interests are busy promoting […]
February 8, 2023 For the past several years, COVID-19 ran rampant and devastated businesses across the country. Especially hard-hit […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/